140 related articles for article (PubMed ID: 34571211)
21. [Method and impact of allografts cryopreservation during the Covid-19 pandemic: guidelines from the SFGM-TC].
Forcade E; Bacquet S; Ballot C; Capin L; Garnier F; Giraud C; Guérout-Vérité MA; Letellier C; Magnani A; Mamez AC; Nasone J; Sinayoko M; Baudoux E; Mialou V; Yakoub-Agha I; Calmels B
Bull Cancer; 2023 Feb; 110(2S):S39-S47. PubMed ID: 35791975
[TBL] [Abstract][Full Text] [Related]
22. Impact of Cryopreservation of Peripheral Blood Stem Cells (PBSC) in Transplantation from Matched Unrelated Donor (MUD).
Facchin G; Savignano C; Battista ML; Isola M; De Martino M; Petruzzellis G; Rosignoli C; Pizzano U; Cerno M; De Cecco G; Bertone A; Barillari G; Fanin R; Patriarca F
J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887878
[TBL] [Abstract][Full Text] [Related]
23. The Effect of the COVID-19 Pandemic on Unrelated Allogeneic Hematopoietic Donor Collections and Safety.
Parmar G; Allan DS; Morris G; Dibdin N; Ganz K; Mostert K; Paulson K; Petraszko T; Stevens N; Seftel MD
Curr Oncol; 2023 Mar; 30(3):3549-3556. PubMed ID: 36975483
[TBL] [Abstract][Full Text] [Related]
24. Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution.
Maurer K; Kim HT; Kuczmarski TM; Garrity HM; Weber A; Reynolds CG; Liney D; Cutler C; Antin JH; Koreth J; Ritz J; Shapiro RM; Romee R; Wu CJ; Soiffer RJ; Nikiforow S; Ho VT; Gooptu M
Blood Adv; 2021 Dec; 5(23):5140-5149. PubMed ID: 34581754
[TBL] [Abstract][Full Text] [Related]
25. Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity.
Reich-Slotky R; Colovai AI; Semidei-Pomales M; Patel N; Cairo M; Jhang J; Schwartz J
Vox Sang; 2008 May; 94(4):351-7. PubMed ID: 18179677
[TBL] [Abstract][Full Text] [Related]
26. Sustained Hematopoietic Engraftment Potential after Prolonged Storage of Cryopreserved Hematopoietic Stem Cells Used in Salvage Autologous Stem Cell Transplantation.
Makhani SS; Oza SP; Reich-Slotky R; Munshi PN; Biran N; Donato ML; Siegel DS; Vesole DH; Naam S; Rowley SD
Transplant Cell Ther; 2022 Jun; 28(6):306.e1-306.e7. PubMed ID: 35248777
[TBL] [Abstract][Full Text] [Related]
27. Changes in Hematopoietic Cell Transplantation Practices in Response to COVID-19: A Survey from the Worldwide Network for Blood & Marrow Transplantation.
Worel N; Shaw BE; Aljurf M; Koh M; Seber A; Weisdorf D; Schwartz J; Galeano S; Kodera Y; Eldridge PW; Hashmi S; Atsuta Y; Szer J; Saber W; Niederwieser D; Greinix HT;
Transplant Cell Ther; 2021 Mar; 27(3):270.e1-270.e6. PubMed ID: 33781537
[TBL] [Abstract][Full Text] [Related]
28. Haemopoietic stem cell transplantation in Australia and New Zealand, 1992-2001: progress report from the Australasian Bone Marrow Transplant Recipient Registry.
Nivison-Smith I; Bradstock KF; Dodds AJ; Hawkins PA; Szer J
Intern Med J; 2005 Jan; 35(1):18-27. PubMed ID: 15667464
[TBL] [Abstract][Full Text] [Related]
29. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.
Körbling M; Huh YO; Durett A; Mirza N; Miller P; Engel H; Anderlini P; van Besien K; Andreeff M; Przepiorka D; Deisseroth AB; Champlin RE
Blood; 1995 Oct; 86(7):2842-8. PubMed ID: 7545476
[TBL] [Abstract][Full Text] [Related]
30. Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN).
Kamani NR; Walters MC; Carter S; Aquino V; Brochstein JA; Chaudhury S; Eapen M; Freed BM; Grimley M; Levine JE; Logan B; Moore T; Panepinto J; Parikh S; Pulsipher MA; Sande J; Schultz KR; Spellman S; Shenoy S
Biol Blood Marrow Transplant; 2012 Aug; 18(8):1265-72. PubMed ID: 22343376
[TBL] [Abstract][Full Text] [Related]
31. A DKMS (German Bone Marrow Donor Center) view on cryopreservation of unrelated donor stem cell products during the Covid-19 pandemic.
Schmidt AH; Buk D; Bernas SN; Mengling T; Neujahr E; van den Brink MRM
Am J Hematol; 2021 Mar; 96(3):E91-E92. PubMed ID: 33368593
[No Abstract] [Full Text] [Related]
32. Serious Stem Cell Donation Events and Recipient Adverse Reactions Related to Severe Acute Respiratory Syndrome Coronavirus 2: Review of Reports to the World Marrow Donor Association.
Pawson R; Anthias C; Cody M; Fechter M; Fournier D; O'Flaherty E; Oliviera D; van Eerden E; Mengling T
Transplant Cell Ther; 2023 Aug; 29(8):522.e1-522.e5. PubMed ID: 37271343
[TBL] [Abstract][Full Text] [Related]
33. Engraftment for CD34 selected stem cell products is not compromised by cryopreservation.
Reich-Slotky R; Bachegowda LS; Ancharski M; Gergis U; van Besien K; Cushing MM
Transfusion; 2016 Apr; 56(4):893-8. PubMed ID: 26661996
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the recovery of cryopreserved and thawed CD34+ and CD3+ cells collected for hematopoietic transplantation.
Fisher V; Khuu H; David-Ocampo V; Byrne K; Pavletic S; Bishop M; Fowler DH; Barrett AJ; Stroncek DF
Transfusion; 2014 Apr; 54(4):1088-92. PubMed ID: 24117879
[TBL] [Abstract][Full Text] [Related]
35. Anti-thymocyte globulin and post-transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell grafts.
Novitzky-Basso I; Remberger M; Chen C; Pasić I; Lam W; Law A; Gerbitz A; Viswabandya A; Lipton JH; Kim DD; Kumar R; Mattsson J; Michelis FV
Eur J Haematol; 2022 Jan; 108(1):61-72. PubMed ID: 34606661
[TBL] [Abstract][Full Text] [Related]
36. Cryopreservation of adult unrelated donor products in hematopoietic cell transplantation: the OneMatch experience and systematic review of the literature.
Aziz J; Morris G; Rizk M; Shorr R; Mercer D; Young K; Allan D
Transfusion; 2017 Nov; 57(11):2782-2789. PubMed ID: 28963719
[TBL] [Abstract][Full Text] [Related]
37. Demand and usage of unrelated donor products for allogeneic haematopoietic cell transplantation during the COVID-19 pandemic: A Canadian Blood Services Stem Cell Registry analysis.
Allan DS; Green M; Morris G; Weiss J; Dibdin N; Mercer D; Seftel M
Vox Sang; 2022 Sep; 117(9):1121-1125. PubMed ID: 35583125
[TBL] [Abstract][Full Text] [Related]
38. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.
Cohen S; Roy J; Lachance S; Delisle JS; Marinier A; Busque L; Roy DC; Barabé F; Ahmad I; Bambace N; Bernard L; Kiss T; Bouchard P; Caudrelier P; Landais S; Larochelle F; Chagraoui J; Lehnertz B; Corneau S; Tomellini E; van Kampen JJA; Cornelissen JJ; Dumont-Lagacé M; Tanguay M; Li Q; Lemieux S; Zandstra PW; Sauvageau G
Lancet Haematol; 2020 Feb; 7(2):e134-e145. PubMed ID: 31704264
[TBL] [Abstract][Full Text] [Related]
39. Has allogeneic stem cell cryopreservation been given the 'cold shoulder'? An analysis of the pros and cons of using frozen versus fresh stem cell products in allogeneic stem cell transplantation.
Frey NV; Lazarus HM; Goldstein SC
Bone Marrow Transplant; 2006 Sep; 38(6):399-405. PubMed ID: 16892075
[TBL] [Abstract][Full Text] [Related]
40. Leukocytapheresis variables and transit time for allogeneic cryopreserved hpc: better safe than sorry.
Fernandez-Sojo J; Horton R; Cid J; Azqueta C; Garcia-Buendia A; Valdivia E; Martorell L; Rubio-Lopez N; Codinach M; Aran G; Marsal J; Mussetti A; Martino R; Diaz-de-Heredia C; Ferra C; Valcarcel D; Linares M; Ancochea A; García-Rey E; García-Muñoz N; Medina L; Carreras E; Villa J; Lozano M; Gibson D; Querol S
Bone Marrow Transplant; 2022 Oct; 57(10):1531-1538. PubMed ID: 35804055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
